Cryptococcosis Market (Treatment - Amphotericin B (Amphocin and Fungizone), Flucytosine (Ancobon), Fluconazole (Diflucan), Voriconazole and Surgery Treatment; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Drug Store, and Mail Order Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Single User License $5795
Cryptococcosis Market Size, Share, Growth, Sales, Trade, Shipment, Export Value And Volume With Sales And Pricing Forecast By 2025

Cryptococcosis Market (Treatment - Amphotericin B (Amphocin and Fungizone), Flucytosine (Ancobon), Fluconazole (Diflucan), Voriconazole and Surgery Treatment; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Drug Store, and Mail Order Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Status : Published | Pharmaceutical |

Report Description


Global Cryptococcosis Market: Overview

Also referred to as cryptococcal diseases, cryptococcosis is a possibly an incurable fungal disease. It is basically caused by the infection of any of these two species such as Cryptococcus gattii and Cryptococcus neoformans. These were all earlier thought to be subspecies of C. neoformans however have now been recognized as particular species.

Cryptococcosis is supposed to be developed by inward breath of the transferrable propagule from the atmosphere. In spite of the fact that the actual nature of the infectious propagule is obscure, the foremost hypothesis is the basidiospore made through asexual or sexual reproduction. Cryptococcosis is an essential artful infection for AIDS, and is the next basic AIDS-defining illness in the African continent. Other circumstances that pose an augmented hazard include certain lymphomas such as Hodgkin's lymphoma, liver cirrhosis, sarcoidosis, and patients on long haul corticosteroid therapy.

The pervasiveness of cryptococcosis has been rising over the previous 20 years for some, reasons, incorporating the rise in the incidence of AIDS and the prolonged employment of immunosuppressive medications.

Global Cryptococcosis Market: Trends and Prospects

One of the key components driving the worldwide cryptococcosis market is the expanding occurrence of cryptococcosis diseases over the world. The quantity of patients experiencing cryptococcosis has been observed to be on the ascent at a quicker rate than beforehand thought. The patients experiencing the contagious contamination are observed to be in high numbers among HIV positive patients. Thusly, the developing number of HIV patients is additionally impelling the demand for cutting edge and successful treatment for the sickness.

Rising activities by non-government and government associations is likewise putting the pipeline advancement in the worldwide cryptococcosis market on the road to success in numerous nations, particularly in developed ones. Be that as it may, the worldwide cryptococcosis market is as of now being influenced by limiting elements, for instance, the expanded mortality among cryptococcosis tainted patients, which diminishes the general extent of testing and diagnostics, and the up and coming patent expiry of key medications which will bring about the substantial scale section of less expensive generics.

One of the key elements keeping the worldwide cryptococcosis market down at present is the high death rate among patients suffering from cryptococcosis. Cryptococcal meningitis and Pneumocystis pneumonia are the two more noteworthy parasitic diseases that prompt demise on the planet. The death rate of HIV patients who get determined to have cryptococcosis is to a great degree near 100%. This gives an extremely minor extent of advancement of existing and pipeline tranquilizes as it can handicap the general testing stage.

Global Cryptococcosis Market: Regional Outlook

North America held the leading share in 2015 in the global cryptococcosis market. It is anticipated to maintain the lead in the market over the course of the forecast period owing to the growing prevalence of the particular infection in certain endemic areas of the United States. Rising number of healthcare services in the region is also one of the core reasons behind the growth of the market in North America. The Middle East and Africa is also expected to show substantial potential in the years ahead.

Global Cryptococcosis Market: Vendor Landscape

The market for cryptococcosis is extremely fragmented with only a handful of companies leading the game. The companies are Sigmapharm Laboratories LLC, Glenmark Pharmaceuticals, Valeant Pharmaceuticals, Inc., Pfizer, Inc., Novartis AG, Abbott Laboratories, Janssen Biotech, and Bristol-Myers Squibb Company.

The global cryptococcosis market has been segmented as given below:

Global Cryptococcosis Market, by Treatment,

  • Amphotericin B
    • Amphocin
    • Fungizone
    • Other
  • Flucytosine
    • Ancobon
    • Other
  • Fluconazole
    • Diflucan
    • Other
  • Others (Voriconazole, surgery treatment, etc.)

Global Cryptococcosis Market, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Store
  • Mail Order Pharmacies
  • Other

Global Cryptococcosis market, by Region

  • North America
    • U.S.
    • Canada
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America

Have Questions on this report?

Click below to Ask An Expert

Ask An Expert